Molecular diagnosis and MRD monitoring in AML

preview_player
Показать описание
Jacqueline Cloos, PhD, Amsterdam University Medical Center, Amsterdam, The Netherlands, gives an update on the role of molecular diagnosis and measurable residual disease (MRD) monitoring in acute myeloid leukemia (AML). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
  1. VJHemOnc – Video Journal of Hematology & HemOnc
  2. Speaker: Jacqueline Cloos
  3. Institution: Amsterdam University Medical Center
  4. Event: VJVirtual
  5. Event: ESH AL 2020
  6. Format: Interview
Рекомендации по теме
Molecular diagnosis and 0:02:35

Molecular diagnosis and MRD monitoring in AML

Molecular techniques for 0:06:39

Molecular techniques for monitoring MRD in AML

Updates on the 0:01:40

Updates on the use of molecular monitoring to detect MRD in AML

Better molecular understanding, 0:00:50

Better molecular understanding, better treatments, and MRD monitoring in AML: 2022 ESMO Florida

MRD Monitoring in 0:50:49

MRD Monitoring in Acute Myeloid Leukemia

Precise Molecular Residual 0:04:17

Precise Molecular Residual Disease (MRD) Test

Minimal Residual Disease 0:56:04

Minimal Residual Disease (MRD) Overview | LRF Ed Forum Series

40 years of 0:56:44

40 years of MRD. A review of flow cytometry as an advanced technique for B-ALL monitoring

Innovations in Hematology 1:15:40

Innovations in Hematology

Can MRD testing 0:05:44

Can MRD testing be done on a blood sample?

What is NGS 0:02:33

What is NGS MRD?

Clinical Use of 0:21:43

Clinical Use of Molecular MRD Testing in AML

The role of 0:02:23

The role of MRD monitoring using MFC for AML: a real-world study

The role of 0:06:00

The role of molecular MRD monitoring in AML/NGS approaches

Measurable Residual Disease 0:22:56

Measurable Residual Disease (MRD) in AML and ALL

CML molecular monitoring: 0:21:14

CML molecular monitoring: Practical advice

Improving the specificity 0:02:15

Improving the specificity of molecular MRD detection

The importance of 0:01:46

The importance of MRD monitoring in AML

MRD detection with 0:02:00

MRD detection with NGS for AML: a new era of diagnostics

ClonoSIGHT: Next Generation 0:33:05

ClonoSIGHT: Next Generation Sequencing Detection of MRD in ALL - Aaron Logan, MD, PhD

Flow cytometry vs. 0:02:32

Flow cytometry vs. molecular methods for MRD testing in acute leukemias

Advances in testing: 0:18:43

Advances in testing: A personalized, ctDNA assay for MRD detection and surveillance

Development of Molecular 0:32:10

Development of Molecular AML MRD Assays

Advancing molecular diagnostics 0:44:08

Advancing molecular diagnostics for Acute Leukemia